Victoria health update
Can I get HRT from a pharmacy without a new prescription in Victoria?
By Patrick LeachPublisher: HerDoc
Eligible Victorians can now have established menopause hormone therapy resupplied at a participating pharmacy after an in-person assessment. The pathway is for stable treatment and does not replace ongoing GP or prescriber reviews.
Sources checked
At a glance
- Who may qualify
- People aged 45–59, or aged 30 or older with confirmed surgical menopause after removal of both ovaries, who meet the other protocol requirements.
- Treatment history
- The same regimen must have controlled symptoms without a dose change for at least six months, with prescribing and a review confirming continuation within the previous 12 months.
- At the pharmacy
- An in-person assessment in a private room, including blood pressure and a reassessment before each supply.
- Supply and cost
- Up to one month per supply. The consultation is free; the medicine is privately paid, is not PBS subsidised and does not count towards the PBS Safety Net.
- Ongoing review
- A GP or other authorised prescriber review is still required at least every 12 months, and earlier if symptoms, health or treatment needs change.
What changed in Victoria?
Yes—participating pharmacies in Victoria can resupply your existing HRT after an assessment, without you needing a new prescription first. This pathway covers continuing suitable treatment, rather than starting HRT or changing your dose. Contact the pharmacy before visiting and keep up your regular reviews with your prescribing practitioner.
The legal conditions are set out in Appendix 8 of the Victorian Government Gazette, and pharmacists must follow the state’s clinical protocol.
Who can use the pharmacy resupply pathway?
The legal age threshold is 45 to 59, or 30 and older with confirmed surgical menopause after removal of both ovaries. The medicine must have been prescribed by a medical practitioner or another authorised prescribing practitioner within the previous 12 months.
The Victorian MHT resupply protocol also requires a review within the previous 12 months confirming that treatment should continue. Symptoms must be adequately controlled on the same regimen, with no dose change for at least six months.
These are threshold rules, not a complete self-checklist. The pharmacist assesses medicines, health changes and relevant risk factors before every supply. If the protocol’s requirements are not met, the pharmacist refers the patient for prescriber care.
What happens at the pharmacy, and what does it cost?
The consultation takes place in person in a private room. The pharmacist checks blood pressure and completes the protocol assessment. If the assessment supports resupply, the pharmacist can provide up to one month of an included MHT medicine. The assessment is repeated before each supply.
The consultation is free, but the medicine is not. The Department of Health’s Community Pharmacist Program resources explain that the medicine is privately funded rather than PBS subsidised. The Chemist Care Now consumer guide also says the purchase does not count towards the PBS Safety Net. Ask the pharmacy what your medicine will cost.
Not every pharmacy provides the service. Contact the pharmacy first to ask whether it participates, whether you need to book and what to bring. The consumer guide suggests taking an old prescription or the medicine in its original box. Dispensing records can help the assessment, but they do not guarantee supply.
Why this extra access option matters
For someone whose treatment is working and unchanged, another appointment may mean time away from paid work, arranging care for children or relatives, or travelling a long distance. Pharmacy resupply may remove some of that friction when the person and treatment fit the protocol.
HerDoc welcomes the additional choice. Its practical value will depend on local pharmacy participation, private medicine costs and each person’s circumstances.
When is a GP or prescriber review still needed?
The protocol requires an MHT review with a GP or another authorised prescriber at least every 12 months. A review may be needed earlier if symptoms persist or change, side effects arise, health or risk factors change, treatment goals shift, or a dose adjustment is being considered.
A pharmacy resupply assessment serves a different purpose from a broader menopause review. Ongoing care can include checking whether treatment still meets your goals, considering other causes of symptoms, discussing benefits and risks, adjusting treatment and keeping preventive health care up to date.
General GP telehealth can complement pharmacy and in-person care by giving you time to discuss symptoms, side effects, goals and relevant history. The doctor decides whether telehealth fits the concern and, under the Medical Board of Australia’s telehealth guidance, arranges in-person care when it is needed. Ask the pharmacy what evidence of your recent prescriber review it accepts.
HerDoc has invested in software intended to help its doctors see a patient’s concerns and history early in a consultation. This supports HerDoc’s aim of making general GP care more practical for women, including people balancing work, caring responsibilities or long travel.
How records support continuity of care
Continuity includes an ongoing clinical relationship and useful information: what was supplied, what was assessed, whether anything changed and what follow-up was advised. That information can help the next clinician understand the earlier care without rebuilding the full history.
The pharmacy protocol requires a consultation record. The consumer guide says you can choose whether to consent to sharing information with your GP or My Health Record, and you can decline without losing access to the pharmacy service. Do not assume the consultation will automatically appear in every clinician’s records.
HerDoc supports meaningful notes being shared with a patient’s usual GP or uploaded to My Health Record when the patient consents. Connected care works best when consented information is accurate, accessible and useful wherever the patient seeks care next.
What to do next
- Check whether your age, prescribing history, recent review and treatment stability appear to meet the threshold rules.
- Ask a participating pharmacy whether it offers MHT resupply, whether you need to book, what to bring and what the medicine will cost.
- Expect an in-person assessment before each supply; resupply is not automatic.
- Arrange a GP or authorised prescriber review at least annually, or earlier if concerns or changes arise.
- Ask what will be recorded and, if you consent, how a useful summary can reach your usual GP or My Health Record.
A note about the published age information
Checked 15 October 2026: the Better Health consumer page says ages 49–59. The controlling Gazette approval and the Department of Health protocol say ages 45–59, so this guide uses 45–59.
Related HerDoc guides
Primary sources
- Victoria Government Gazette G 40, Appendix 8 Legal age, prescribing, stability and pharmacist requirements.
- Protocol for Resupply of Menopausal Hormone Therapy Eligibility, assessment, supply, review and record-sharing requirements.
- Community Pharmacist Program resources Program scope and cost information.
- Chemist Care Now Consumer preparation, costs and consent information; see the age discrepancy note above.
- More Care Closer To Home At Your Local Pharmacy Victorian Government announcement dated 7 October 2026.
- Medical Board of Australia telehealth consultations guidance Doctor responsibilities for deciding whether telehealth is suitable and arranging in-person care when needed.